MUHAMMAD MURAD: Open Payments
NPI 1568924462 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,783 in 169 payments from 20 companies in 2025. Trend: 2023 $622 · 2024 $767 · 2025 $2,783
Food & beverage: $2,671Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 31 | $553 |
| Janssen Pharmaceuticals, Inc | 20 | $452 |
| Otsuka America Pharmaceutical, Inc. | 29 | $295 |
| Lundbeck LLC | 14 | $208 |
| Neurocrine BioSciences, Inc. | 10 | $173 |
| E.R. Squibb & Sons, L.L.C. | 10 | $145 |
| Alkermes, Inc. | 12 | $143 |
| Vanda Pharmaceuticals Inc. | 7 | $136 |
| Collegium Pharmaceutical, Inc. | 9 | $136 |
| Corium, LLC | 7 | $129 |
Products named: REXULTI, UZEDY, INVEGA SUSTENNA, SPRAVATO, INGREZZA, COBENFY, FANAPT, Jornay PM.
Industry payments across TX — which companies pay providers there.
